Raising the Index of Suspicion in Primary Care: The Role of the Nurse Practitioner in Recognizing and Managing Diabetic Kidney Disease Evaluation (ID: i816b-1)

Question Title

* 1. How many years have you been in practice?

>21

11-20

1-10

Question Title

* 2. How many patients with DKD do you manage per week? 

1 to 10

11 to 25

26 to 50

I am not directly involved in patient care

Question Title

* 3. Please select the option that best describes your practice setting:

Hospital Network

Institutional Setting (skilled-nursing facilities, correctional facilities, mental hospitals and psychiatric units)

Retail Pharmacy

Urgent Care

Private Practice

Group Practice

Other (please specify)

Question Title

* 4. After participating in this activity, how confident are you in the management of patients with DKD in your practice?

Very confident

Confident

Neutral

Little confidence

No confidence

Question Title

* 5. How committed are you to making changes in your practice based on your participation in this activity?

Very committed

Committed

Neutral

Not committed

I do not plan to make changes

If not committed or do not plan to make changes, please indicate reason

Question Title

* 6. Which of the following best describes the impact of this activity on your performance?

I gained new strategies/skills/information I can apply to my area of practice

I need more information before I can change my practice

My practice is already consistent with the information presented

This activity will not change my practice

Question Title

* 7. Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.

Increase frequency of screening for DKD in patients with diabetes

Monitor serum creatinine and potassium levels in patients with diabetes

More vigilantly monitor CV risk in patients with diabetes and kidney disease

Consider clinical strategies that reduce the effects of aldosterone on inflammation and fibrosis

Incorporate therapies that improve DKD outcomes in the management of patients with diabetes

Question Title

* 8. What barriers do you see to making changes in your practice? Please select all that apply.

Lack of knowledge regarding evidence-based strategies

Lack of convincing evidence to warrant change

Lack of time/resources to consider change

Insurance, reimbursement or legal issues

Conflicting guidelines or evidence

Patient compliance and/or patient resource barriers

Other (please specify)

Question Title

* 9. Please rate your level of agreement by checking the appropriate rating.
5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree

After participating in today’s activity, I am now better able to:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
List recommended screening strategies to ensure early diagnosis of chronic kidney disease (CKD) in patients with diabetes, including the use of urine albumin-to-creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR)	List recommended screening strategies to ensure early diagnosis of chronic kidney disease (CKD) in patients with diabetes, including the use of urine albumin-to-creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR) Strongly agree	List recommended screening strategies to ensure early diagnosis of chronic kidney disease (CKD) in patients with diabetes, including the use of urine albumin-to-creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR) Agree	List recommended screening strategies to ensure early diagnosis of chronic kidney disease (CKD) in patients with diabetes, including the use of urine albumin-to-creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR) Neutral	List recommended screening strategies to ensure early diagnosis of chronic kidney disease (CKD) in patients with diabetes, including the use of urine albumin-to-creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR) Disagree	List recommended screening strategies to ensure early diagnosis of chronic kidney disease (CKD) in patients with diabetes, including the use of urine albumin-to-creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR) Strongly disagree
Discuss how diabetic kidney disease (DKD) confers a high risk of cardiovascular disease (CVD), renal events, and associated mortality, and DKD’s implications for patient management	Discuss how diabetic kidney disease (DKD) confers a high risk of cardiovascular disease (CVD), renal events, and associated mortality, and DKD’s implications for patient management Strongly agree	Discuss how diabetic kidney disease (DKD) confers a high risk of cardiovascular disease (CVD), renal events, and associated mortality, and DKD’s implications for patient management Agree	Discuss how diabetic kidney disease (DKD) confers a high risk of cardiovascular disease (CVD), renal events, and associated mortality, and DKD’s implications for patient management Neutral	Discuss how diabetic kidney disease (DKD) confers a high risk of cardiovascular disease (CVD), renal events, and associated mortality, and DKD’s implications for patient management Disagree	Discuss how diabetic kidney disease (DKD) confers a high risk of cardiovascular disease (CVD), renal events, and associated mortality, and DKD’s implications for patient management Strongly disagree
Describe the role of inflammation, fibrosis, and the mineralocorticoid receptor in the progression of DKD	Describe the role of inflammation, fibrosis, and the mineralocorticoid receptor in the progression of DKD Strongly agree	Describe the role of inflammation, fibrosis, and the mineralocorticoid receptor in the progression of DKD Agree	Describe the role of inflammation, fibrosis, and the mineralocorticoid receptor in the progression of DKD Neutral	Describe the role of inflammation, fibrosis, and the mineralocorticoid receptor in the progression of DKD Disagree	Describe the role of inflammation, fibrosis, and the mineralocorticoid receptor in the progression of DKD Strongly disagree
Describe how to incorporate current treatment approaches and discuss novel treatment approaches based on current and emerging data, to optimize the care of patients with type 2 diabetes and decrease the risk of progression of DKD	Describe how to incorporate current treatment approaches and discuss novel treatment approaches based on current and emerging data, to optimize the care of patients with type 2 diabetes and decrease the risk of progression of DKD Strongly agree	Describe how to incorporate current treatment approaches and discuss novel treatment approaches based on current and emerging data, to optimize the care of patients with type 2 diabetes and decrease the risk of progression of DKD Agree	Describe how to incorporate current treatment approaches and discuss novel treatment approaches based on current and emerging data, to optimize the care of patients with type 2 diabetes and decrease the risk of progression of DKD Neutral	Describe how to incorporate current treatment approaches and discuss novel treatment approaches based on current and emerging data, to optimize the care of patients with type 2 diabetes and decrease the risk of progression of DKD Disagree	Describe how to incorporate current treatment approaches and discuss novel treatment approaches based on current and emerging data, to optimize the care of patients with type 2 diabetes and decrease the risk of progression of DKD Strongly disagree

Question Title

* 10. Please rate your level of agreement by checking the appropriate rating.
5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
The faculty presenter (Kathleen Byrne, MSN, CRNP, FPCNA, CLS, FNLA) effectively presented the material	The faculty presenter (Kathleen Byrne, MSN, CRNP, FPCNA, CLS, FNLA) effectively presented the material Strongly agree	The faculty presenter (Kathleen Byrne, MSN, CRNP, FPCNA, CLS, FNLA) effectively presented the material Agree	The faculty presenter (Kathleen Byrne, MSN, CRNP, FPCNA, CLS, FNLA) effectively presented the material Neutral	The faculty presenter (Kathleen Byrne, MSN, CRNP, FPCNA, CLS, FNLA) effectively presented the material Disagree	The faculty presenter (Kathleen Byrne, MSN, CRNP, FPCNA, CLS, FNLA) effectively presented the material Strongly disagree
The faculty presenter demonstrated experiential knowledge of the topic	The faculty presenter demonstrated experiential knowledge of the topic Strongly agree	The faculty presenter demonstrated experiential knowledge of the topic Agree	The faculty presenter demonstrated experiential knowledge of the topic Neutral	The faculty presenter demonstrated experiential knowledge of the topic Disagree	The faculty presenter demonstrated experiential knowledge of the topic Strongly disagree
The faculty for this activity was knowledgeable	The faculty for this activity was knowledgeable Strongly agree	The faculty for this activity was knowledgeable Agree	The faculty for this activity was knowledgeable Neutral	The faculty for this activity was knowledgeable Disagree	The faculty for this activity was knowledgeable Strongly disagree

Question Title

* 11. The content presented:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Enhanced my current knowledge base	Enhanced my current knowledge base Strongly agree	Enhanced my current knowledge base Agree	Enhanced my current knowledge base Neutral	Enhanced my current knowledge base Disagree	Enhanced my current knowledge base Strongly disagree
Addressed my most pressing questions	Addressed my most pressing questions Strongly agree	Addressed my most pressing questions Agree	Addressed my most pressing questions Neutral	Addressed my most pressing questions Disagree	Addressed my most pressing questions Strongly disagree
Promoted improvements or quality in health care	Promoted improvements or quality in health care Strongly agree	Promoted improvements or quality in health care Agree	Promoted improvements or quality in health care Neutral	Promoted improvements or quality in health care Disagree	Promoted improvements or quality in health care Strongly disagree
Was scientifically rigorous and evidence based	Was scientifically rigorous and evidence based Strongly agree	Was scientifically rigorous and evidence based Agree	Was scientifically rigorous and evidence based Neutral	Was scientifically rigorous and evidence based Disagree	Was scientifically rigorous and evidence based Strongly disagree
Provided a fair and balanced coverage of the topic	Provided a fair and balanced coverage of the topic Strongly agree	Provided a fair and balanced coverage of the topic Agree	Provided a fair and balanced coverage of the topic Neutral	Provided a fair and balanced coverage of the topic Disagree	Provided a fair and balanced coverage of the topic Strongly disagree
The teaching and learning methods in this activity were effective	The teaching and learning methods in this activity were effective Strongly agree	The teaching and learning methods in this activity were effective Agree	The teaching and learning methods in this activity were effective Neutral	The teaching and learning methods in this activity were effective Disagree	The teaching and learning methods in this activity were effective Strongly disagree
Was free from commercial bias	Was free from commercial bias Strongly agree	Was free from commercial bias Agree	Was free from commercial bias Neutral	Was free from commercial bias Disagree	Was free from commercial bias Strongly disagree

Question Title

* 12. Overall, was this activity fair and balanced

Yes

If No, please explain:

Question Title

* 13. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 14. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities for this or a related disease state:

Question Title

* 1. How many years have you been in practice?

Question Title

* 2. How many patients with DKD do you manage per week?

Question Title

* 3. Please select the option that best describes your practice setting:

Question Title

* 4. After participating in this activity, how confident are you in the management of patients with DKD in your practice?

Question Title

* 5. How committed are you to making changes in your practice based on your participation in this activity?

Question Title

* 6. Which of the following best describes the impact of this activity on your performance?

Question Title

* 7. Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.

Question Title

* 8. What barriers do you see to making changes in your practice? Please select all that apply.

Question Title

* 9. Please rate your level of agreement by checking the appropriate rating. 5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagreeAfter participating in today’s activity, I am now better able to:

Question Title

* 10. Please rate your level of agreement by checking the appropriate rating. 5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree

Question Title

* 11. The content presented:

Question Title

* 12. Overall, was this activity fair and balanced

Question Title

* 13. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 14. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities for this or a related disease state:

Question Title

* 15. If you indicated that you perceived commercial bias or influence, please describe:

* 2. How many patients with DKD do you manage per week? 

* 9. Please rate your level of agreement by checking the appropriate rating.
5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree

After participating in today’s activity, I am now better able to:

* 10. Please rate your level of agreement by checking the appropriate rating.
5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree